Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_assertion type Assertion NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_head.
- NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_assertion description "[This review discusses the most promising vaccination strategies for non-small cell lung cancer including the allogeneic tumor cell vaccine belagenpumatucel-L, which is a mixture of 4 allogeneic non-small cell lung cancer cell lines genetically modified to secrete an antisense oligonucleotide to transforming growth factor ?2 and 3 other target protein-specific vaccines designed to induce responses against melanoma-associated antigen A3, mucin 1, and epidermal growth factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_provenance.
- NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_assertion evidence source_evidence_literature NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_provenance.
- NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_assertion SIO_000772 21952280 NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_provenance.
- NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_assertion wasDerivedFrom befree-20140225 NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_provenance.
- NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_assertion wasGeneratedBy ECO_0000203 NP848803.RAbpqz0a9GnhklILLYMLkal2BkTLXOnTJUs6lX9abfDXE130_provenance.